Hui Xing

A phase II trial of docetaxel plus nedaplatin and 5-fluorouracil in treating advanced esophageal carcinoma.

B. Zhang, Feng Wu, Jing Guo, 2010, Chinese journal of cancer.

Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma

Hui Li, Qinggang Li, Qinggang Li, 2015, World Journal of Surgical Oncology.

Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study

W. Lau, W. Cong, Huichuan Sun, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity

Yang Wang, Qi Wei, Hui Xing, 2023, Translational oncology.

Development and Validation of a Novel Model for Predicting Prognosis of Non-PCR Patients After Neoadjuvant Therapy for Breast Cancer

Yueping Liu, Meng Han, Jinze Li, 2021, Frontiers in Oncology.

Clinical observation of pediatric-type follicular lymphomas in adult: Two case reports

Yueping Liu, Hui Xing, Yao Liu, 2021, World journal of clinical cases.

Tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in relation to pathological complete remission to neoadjuvant therapy and prognosis in triple negative breast cancer.

Xinran Wang, Meng Zhao, Jiankun He, 2023, Pathology, research and practice.

Molecular targeted therapy and immunotherapy in advanced hepatocellular carcinoma: a systematic review and Bayesian network meta-analysis based on randomized controlled trials

H. Ning, Guangzhi Wang, Hui Xing, 2023, Annals medicus.